| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/14/2007 | EP1515949B1 Mitotic kinesin inhibitors |
| 03/14/2007 | EP1502595B1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof |
| 03/14/2007 | EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same |
| 03/14/2007 | EP1448235B1 Oral controlled release pharmaceutical compositions of 5,8,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 03/14/2007 | EP1406897B1 Compounds |
| 03/14/2007 | EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 03/14/2007 | EP1337238B1 Generation of therapeutic microfoam |
| 03/14/2007 | EP1305434B1 A human disintegrin protein |
| 03/14/2007 | EP1259262B1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 03/14/2007 | EP1224302B1 Modified viral surface proteins which bind to cells of tumor vasculature |
| 03/14/2007 | EP1189623B1 Method and composition for inhibiting cardiovascular cell proliferation |
| 03/14/2007 | EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 03/14/2007 | EP1011637B1 Modulation of drug loading in multivesicular liposomes |
| 03/14/2007 | EP0998471B1 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 03/14/2007 | CN1930288A Cells of which genome is modified |
| 03/14/2007 | CN1930180A L-saccharide glucose lipid a analogue |
| 03/14/2007 | CN1930155A Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 03/14/2007 | CN1930150A Pyrazolyl indolyl derivatives as PPAR activators |
| 03/14/2007 | CN1930145A Cycloalkanopyridine derivative |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1930123A Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 03/14/2007 | CN1929847A Fasudil-containing preparation and method of improving stability thereof |
| 03/14/2007 | CN1929845A Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| 03/14/2007 | CN1928113A Function and application of RhoA/ROK alpha signal conduction path in blood vessel adventitia reconstruction |
| 03/14/2007 | CN1928112A Expression of VEGF I type receptor on blood vessel adventitia fibroblast |
| 03/14/2007 | CN1928111A Correlation analysis of circulation endothelium progenitor cell and coronary artery pathological changes |
| 03/14/2007 | CN1927381A Medicine comprising rilmenidine |
| 03/14/2007 | CN1927368A Medicine for curing cardiovascular disease and its preparation method |
| 03/14/2007 | CN1927350A Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases |
| 03/14/2007 | CN1927346A Mailuoning injection and preparation thereof |
| 03/14/2007 | CN1927343A Pharmaceutical composition of gen-seng or red ginseng, ophiopogon root and breviscapine |
| 03/14/2007 | CN1927341A Breviscapus pulse-engendering soft capsule and its preparing process |
| 03/14/2007 | CN1927339A Complex traditional Chinese medicine preparation for treating myocardial ischemia and improving microcirculation and preparing method thereof |
| 03/14/2007 | CN1927331A Chinese medicine preparation for curing chronic heart failure |
| 03/14/2007 | CN1927329A Medicine for curing cardiovascular disease and its preparation method |
| 03/14/2007 | CN1927328A Traditional Chinese medicine composition for treating hemorrhoid, anus and pudendum disease and its using method |
| 03/14/2007 | CN1927312A Grape extract containing medicine composition and its preparation and use |
| 03/14/2007 | CN1927306A Chinese medicine for treating cardiopathy and preparing method thereof |
| 03/14/2007 | CN1927305A Use of Tibet picrorhiza rhizome in preparation of medicine for treating atherosclerosis |
| 03/14/2007 | CN1927301A Tongmai Jiangzhi dispersant tablet and method for making same |
| 03/14/2007 | CN1927290A Ointment for treating naevus and preparing method thereof |
| 03/14/2007 | CN1927255A Compound recipe medicine for treating apoplexy and its preparation method |
| 03/14/2007 | CN1927247A Composition of barrenwort extract and puerarin, preparation process and use thereof |
| 03/14/2007 | CN1927242A Composition of notoginsen triterpenes and tanshinone IIA sodium sulfonate |
| 03/14/2007 | CN1927241A Pharmaceutical composition of ligustrazine and notoginsen triterpenes |
| 03/14/2007 | CN1927235A Lunar caustic composition and preparing method and use thereof |
| 03/14/2007 | CN1927219A Hemorrhoid injection |
| 03/14/2007 | CN1927216A Compound recipe Breviscapine injection and its preparing method |
| 03/14/2007 | CN1927214A Injection for treating cerebrovascular disease and its preparing process |
| 03/14/2007 | CN1927211A Production method of phosphoric ligustrazine drop |
| 03/14/2007 | CN1927204A Pharmaceutical composition of ligustrazine and carthamus tinctorius yellow color |
| 03/14/2007 | CN1927202A Vitamin E nicotinate microcapsule and its preparing process |
| 03/14/2007 | CN1927200A Bilobalide self-tiny-emulsifying soft capsule and its preparing process |
| 03/14/2007 | CN1927184A Production method of erigeron breviscopus element drop |
| 03/14/2007 | CN1304415C Pyrane derivatives as both ACE- and NEP- inhibitors |
| 03/14/2007 | CN1304390C Novel gamma secretase inhibitors |
| 03/14/2007 | CN1304383C Benzothiazole derivatives |
| 03/14/2007 | CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 03/14/2007 | CN1304379C Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions |
| 03/14/2007 | CN1304374C Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition |
| 03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 03/14/2007 | CN1304058C Water soluble paclitaxel prodrugs |
| 03/14/2007 | CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 03/14/2007 | CN1304039C Chinese medicine composition with functions of reducing blood-pressure, reducing-fat, anti-dizzy and calming wind, its preparing method and use |
| 03/14/2007 | CN1304036C Blood pressure reducing and blood fat removing healthy compositions |
| 03/14/2007 | CN1304017C Capsule for activating vital energy and promoting blood circulation |
| 03/14/2007 | CN1304016C Spraying agent for curing chest stuffiness and anginal |
| 03/14/2007 | CN1304014C Capsule for curing haemorrhoids |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/14/2007 | CN1304008C Medical compsns. |
| 03/14/2007 | CN1304005C Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 03/14/2007 | CN1304000C Use of valsartan in preparing drug for treating lung cancer |
| 03/14/2007 | CN1303999C Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 03/14/2007 | CN1303997C Method for preparing artemisine and its liposoluble derivatives emulsion |
| 03/14/2007 | CN1303990C Sodium ferulate oral disintegrating tablet and its preparation process |
| 03/14/2007 | CN1303987C Esmolol Hydrochloride freeze dried powder for injection and its preparation method |
| 03/14/2007 | CN1303980C Orally quick releasing tablet of compound red sage root, its medical uses and preparation process |
| 03/14/2007 | CN1303979C Snake gallbladder and tangerine peel dispersed tablets and preparation method thereof |
| 03/13/2007 | US7190998 Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the BBB and cerbral blood flow |
| 03/13/2007 | US7189878 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 03/13/2007 | US7189870 Cardiovascular disorders; antiinflammatory agents |
| 03/13/2007 | US7189861 Ball milling any crystalline form of atorvastatin hemi-calcium to obtain a polymorphic crystal structure with small particle size distribution; monodispersity; improved physical properties of filtration/drying characteristics, flowability, vapor impermeability, solubility; drug-releasing design |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189809 Genetic engineered ioslated polynucleotide; anticholesterol agents, Alzheimer's disease, antilipemic agents |
| 03/13/2007 | US7189801 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 03/13/2007 | US7189761 Nitric oxide donor composition and method for treatment of anal disorders |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
| 03/13/2007 | US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders |
| 03/13/2007 | US7189738 Substituted isoindoles and their use thereof |
| 03/13/2007 | US7189733 Compositions and methods for inhibiting TGF-β |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | US7189711 Muscle relaxants; central nervous system disorders; Parkinson's disease; Alzheimer's disease; strokes |